相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adnectins: engineered target-binding protein therapeutics
D. Lipovsek
PROTEIN ENGINEERING DESIGN & SELECTION (2011)
Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Positive Tumor with a 64Cu Labeled Affibody Protein
Zheng Miao et al.
BIOCONJUGATE CHEMISTRY (2010)
Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
Christian Zahnd et al.
CANCER RESEARCH (2010)
Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma
Gang Niu et al.
CLINICAL CANCER RESEARCH (2010)
Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-ZEGFR:2377 Affibody molecule: aspect of the injected tracer amount
Vladimir Tolmachev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Stability and CDR Composition Biases Enrich Binder Functionality Landscapes
Benjamin J. Hackel et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Evaluation of a 64Cu-Labeled Cystine-Knot Peptide Based on Agouti-Related Protein for PET of Tumors Expressing αvβ3 Integrin
Lei Jiang et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
[C-11]Gefitinib ([C-11]Iressa): Radiosynthesis, In Vitro Uptake, and In Vivo Imaging of Intact Murine Fibrosarcoma
Ming-Rong Zhang et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
64Cu-Labeled Affibody Molecules for Imaging of HER2 Expressing Tumors
Zhen Cheng et al.
MOLECULAR IMAGING AND BIOLOGY (2010)
Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF
Heewa Kareem et al.
TUMOR BIOLOGY (2010)
Positron Emission Tomography (PET) Imaging with [11C]-Labeled Erlotinib: A Micro-PET Study on Mice with Lung Tumor Xenografts
Ashfaque A. Memon et al.
CANCER RESEARCH (2009)
Engineered Knottin Peptides: A New Class of Agents for Imaging Integrin Expression in Living Subjects
Richard H. Kimura et al.
CANCER RESEARCH (2009)
PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models
Gang Niu et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
Vladimir Tolmachev et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules
Gabriela Kramer-Marek et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
Anna Orlova et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Michael M. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Influence of the Molecular Charge on the Biodistribution of Bombesin Analogues Labeled with the [99mTc(CO)3]-Core
Elisa Garcia Garayoa et al.
BIOCONJUGATE CHEMISTRY (2008)
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules
Sara Ahlgren et al.
BIOCONJUGATE CHEMISTRY (2008)
Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors
Wen Ping Li et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Small-animal PET Imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules
Zhen Cheng et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT
Lea Olive Tchouate Gainkam et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression
Lieven Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer
Thorsten Schlomm et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer
Yago Nieto et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Assessment of 11C-labeled-4-N-(3-bromoanilino)-6,7-dimethoxyquinazoline as a positron emission tomography agent to monitor epidermal growth factor receptor expression
Hui Wang et al.
CANCER SCIENCE (2007)
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery
Gennaro Galizia et al.
WORLD JOURNAL OF SURGERY (2007)
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
Weibo Cai et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy
I. Zlobec et al.
BRITISH JOURNAL OF CANCER (2007)
Influence of different spacers on the biological profile of a DOTA-somatostatin analogue
Patricia Antunes et al.
BIOCONJUGATE CHEMISTRY (2007)
分享论文
